Thomas Flaten
Stock Analyst at Lake Street
(3.04)
# 1,037
Out of 5,058 analysts
32
Total ratings
38.24%
Success rate
4.55%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.26 | +176.07% | 1 | Nov 13, 2025 | |
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $4.88 | +125.41% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $39.60 | +76.77% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $7.65 | +69.93% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $4.36 | +83.49% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $7.30 | +91.78% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.00 | +300.00% | 1 | Jul 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $60 → $40 | $6.90 | +479.71% | 1 | May 14, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $34.65 | +1.01% | 6 | May 6, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $5.83 | +37.22% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $8.24 | +9.22% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.75 | +300.53% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.32 | +154.63% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $24.40 | +2.48% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $1.83 | +78,588.52% | 2 | Nov 17, 2022 |
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.26
Upside: +176.07%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $4.88
Upside: +125.41%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $39.60
Upside: +76.77%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $7.65
Upside: +69.93%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $4.36
Upside: +83.49%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $7.30
Upside: +91.78%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.00
Upside: +300.00%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $6.90
Upside: +479.71%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $34.65
Upside: +1.01%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $5.83
Upside: +37.22%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $8.24
Upside: +9.22%
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.75
Upside: +300.53%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.32
Upside: +154.63%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $24.40
Upside: +2.48%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $1.83
Upside: +78,588.52%